No Data
No Data
Theta Edge Malaysia 2nd-Quarter 2024 Earnings Summary Table
THETA: Quarterly rpt on consolidated results for the financial period ended 30/06/2024
MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor
Theta Edge's Major Shareholder Threadstone Looking to Invest in MSM Johor
Theta Gold Mines Expands Equity With New Options
Theta Gold Mines Director's Holdings Update
No Data
103183538 : Run fast. See for yourself.